Reflex Sympathetic Dystrophy Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Trial Readiness and Endpoint Assessment in Congenital and Childhood Myotonic Dystrophy
Conditions: CDM; ChDM Sponsors: Fondazione Serena Onlus - Centro Clinico NeMO Milano; Bambino Ges ù Hospital and Research Institute; Fondazione Policlinico Universitario Agostino Gemelli IRCCS; IRCCS Istituto delle Scienze Neurologiche di Bologna; IRCCS Fondazione Stella Maris; IRCCS Istituto Neurologico Mondino, Pavia, Italy; Azienda Ospedaliera Città della Salute e della Scienza di Torino; F ondazione I.R.C.C.S. Istituto Neurologico Carlo Besta; Istituto Giannina Gaslini Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2024 Category: Research Source Type: clinical trials

An Observational Study Comparing Delandistrogene Moxeparvovec With Standard of Care in Participants With Duchenne Muscular Dystrophy
Conditions: Duchenne Muscular Dystrophy Interventions: Genetic: delandistrogene moxeparvovec; Drug: Standard of Care Sponsors: Sarepta Therapeutics, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2024 Category: Research Source Type: clinical trials

Evaluation of Cognitive Functions in 20 Patients With Type 1 Myotonic Dystrophy With Virtual Reality Approach
Conditions: Myotonic Dystrophy 1 Interventions: Diagnostic Test: Type 1 myotonic dystrophy Sponsors: Centre Hospitalier Universitaire de Nice Withdrawn (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2024 Category: Research Source Type: clinical trials

Autonomic Dysfunction in Temporal Lobe Epilepsy and SUDEP
Conditions: Temporal Lobe Epilepsy Interventions: Diagnostic Test: Sympathetic skin response, heart rate variability test, quantitative EEG Sponsors: Cairo University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2024 Category: Research Source Type: clinical trials

Plasma Rich in Growth Factors in Corneal Endothelial Transplantation
Conditions: Fuchs ' Endothelial Dystrophy; Corneal Edema Interventions: Procedure: PRGF Sponsors: Price Vision Group Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2024 Category: Research Source Type: clinical trials

Effects of a Supervised Rehabilitation Program on Disease Severity in Spastic Ataxias
Conditions: ARSACS; SPG7 Interventions: Procedure: IMPACT - rehabIlitation prograM for sPAstiC aTaxias Sponsors: Universit é du Québec à Chicoutimi; McGill University; Université de Sherbrooke; Université du Québec a Montréal; Laval University; University of Calgary; Corporation de recherche et d ' action sur les maladies h éréditaires (CORAMH); Cégep de Jonquière; Centre intégré universitaire de santé et de services sociaux du Saguenay-Lac-St-Jean; Muscular Dystrophy Canada; University of Alberta; Integrated University Health and Social Services Center of the Capitale-Nationale Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2024 Category: Research Source Type: clinical trials

Edgewise Receives U.S. FDA Fast Track Designation for EDG-5506 for the Treatment of Duchenne Muscular Dystrophy
BOULDER, Colo.--(BUSINESS WIRE) February 13, 2024 -- Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - February 13, 2024 Category: Pharmaceuticals Source Type: clinical trials

A Trial to Learn More About an Experimental Gene Therapy Called Bidridistrogene Xeboparvovec (SRP-9003) as a Possible Treatment for Limb Girdle Muscular Dystrophy 2E/R4 (EMERGENE)
Conditions: Limb-girdle Muscular Dystrophy Interventions: Biological: SRP-9003; Drug: Glucocorticoid Sponsors: Sarepta Therapeutics, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2024 Category: Research Source Type: clinical trials

Ph2 Open-label Study of AOC 1044 in Duchenne Muscular Dystrophy Participants With Mutations Amenable to Exon44 Skipping
Conditions: DMD; Duchenne Muscular Dystrophy; Duchenne; Exon 44 Interventions: Drug: AOC 1044 Sponsors: Avidity Biosciences, Inc. Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2024 Category: Research Source Type: clinical trials

The Success of Lumbar Sympathetic Ganglion Block Using Lower Extremity Perfusion Index
Conditions: Chronic Pain; Complex Regional Pain Syndromes; Peripheral Neuropathy; Post Herpetic Neuralgia Interventions: Procedure: Lumbar Sympathetic Ganglion Block Sponsors: Jeongsoo Kim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials

A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) Following Imlifidase Infusion in Participants With Duchenne Muscular Dystrophy (DMD) Determined to Have Pre-existing Antibodies to Recombinant Adeno-Associated Virus Serotype (rAAVrh74)
Conditions: Duchenne Muscular Dystrophy Interventions: Genetic: delandistrogene moxeparvovec; Biological: imlifidase Sponsors: Sarepta Therapeutics, Inc.; Hansa Biopharma AB Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials

18F-mFBG Expression in Neural Crest Tumors and Organs Innervated by the Sympathetic Nervous System
Conditions: Neuroblastoma; Pheochromocytoma; Paraganglioma Interventions: Drug: 18F-mFBG Sponsors: Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC); Albert Einstein College of Medicine Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials

Magnetic Resonance Imaging and Ultrasound Comparison With Load Evaluation
Conditions: Muscular Dystrophy, Facioscapulohumeral Interventions: Diagnostic Test: Muscle ultrasound with surface electromyography and dynamometry; Diagnostic Test: MRI scan Sponsors: Radboud University Medical Center; Solve FSHD Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2024 Category: Research Source Type: clinical trials

A Bicentric, Randomized, Double Blind, Placebo-controlled Pilot Study to Evaluate the Efficacy and Safety of Satralizumab in FSHD1
Conditions: Facioscapulohumeral Muscular Dystrophy 1 Interventions: Drug: Satralizumab Prefilled Syringe; Drug: Placebo Comparator Sponsors: Centre Hospitalier Universitaire de Nice Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials

Non Motoric Reactions in Vojta Reflex Locomotion
Conditions: Locomotion Disorder, Neurologic Interventions: Other: Reflex locomotion according to Vojta Sponsors: Charles University, Czech Republic Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials